Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $1.37 USD
Change Today -0.029 / -2.07%
Volume 553.6K
GALE On Other Exchanges
As of 10:35 AM 04/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mark W. Schwartz Ph.D.

Chief Executive Officer, President, Director and Member of Ad Hoc (Strategy, Pricing, Etc) Committee, Galena Biopharma, Inc.
AgeTotal Calculated CompensationThis person is connected to 20 board members in 2 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2013


Dr. Mark W. Schwartz, Ph.D., has been the Chief Executive Officer and President of Galena Biopharma, Inc,. since August 2014. Dr. Schwartz served as the Chief Operating Officer and Executive Vice President at Galena Biopharma, Inc., until August 2014. Dr. Schwartz served as the Chief Executive Officer and President at Apthera, Inc. since January 2010. Dr. Schwartz served as the Chief Executive Officer and President of Bayhill Therapeutics Inc. from March 2004 to September ...

Read Full Background

Corporate Headquarters*

4640 SW Macadam Avenue
Portland, Oregon 97239

United States

Phone: 855-855-4253
Fax: 503- 400-6611

Board Members Memberships*

Chief Executive Officer, President, Director and Member of Ad Hoc (Strategy, Pricing, Etc) Committee
Former Chief Executive Officer and President
Chief Executive Officer, President and Director


Grinnell College
Arizona State University-Tempe

Other Affiliations*

Annual Compensation*

Total Annual Compensation$490,000

Stock Options*

All Other Compensation$693
Exercisable Options417,695
Unexercisable Options622,305
Total Number of Options1,040,000

Total Compensation*

Total Annual Cash Compensation$490,693
Total Short Term Compensation$490,000
Other Long Term Compensation$693
Total Calculated Compensation$1,584,333
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GALE:US $1.37 USD -0.0299


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GALENA BIOPHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at